Biotech Stocks Today: FDA Shifts, ASH 2025 Winners and Market Close Recap (December 9, 2025)
Biotech investors faced a dense catalyst calendar on Tuesday, December 9, 2025, as new U.S. Food and Drug Administration signals on cell and gene therapy, fresh designations in hematologic cancers and high‑impact clinical data from the American Society of Hematology meeting collided with a wave of secondary offerings.